Directors’ / PDMR Dealing and Grant of Opt... | 29-Apr-2024 | 07:00 | RNS |
Results for the Year ended 31 December 2023 | 10-Apr-2024 | 07:00 | RNS |
Notice of Results and Investor Presentation | 25-Mar-2024 | 07:00 | RNS |
Trading Update | 06-Feb-2024 | 07:01 | RNS |
Appointment of Joint Corporate Broker | 06-Feb-2024 | 07:00 | RNS |
Director/PDMR Dealing | 17-Jan-2024 | 07:00 | RNS |
Remuneration of Non-Exec Directors & Voting Rights | 17-Jan-2024 | 07:00 | RNS |
Futura Medical extends collaboration with Cooper | 15-Jan-2024 | 07:00 | RNS |
Appointment of Roy Davis as Non-Executive Director | 09-Jan-2024 | 07:00 | RNS |
Total Voting Rights | 30-Nov-2023 | 15:10 | RNS |
Block Listing Six Monthly Return | 30-Nov-2023 | 15:10 | RNS |
Futura expands partnership with M8 Pharmaceuticals | 07-Nov-2023 | 07:00 | RNS |
Block Listing Application and Total Voting Rights | 31-Oct-2023 | 07:00 | RNS |
Directors’/PDMR Dealing and G... | 10-Oct-2023 | 07:00 | RNS |
European Patent Granted for MED3000 until 2040 | 02-Oct-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 36.50p |
Change Today | 2.50p |
% Change | 7.35 % |
52 Week High | 65.00 |
52 Week Low | 25.50 |
Volume | 732,442 |
Shares Issued | 301.45m |
Market Cap | £110.03m |
Beta | 0.05 |
RiskGrade | 479 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
15:25 | 2,733 @ 36.74p |
15:14 | 10,794 @ 37.00p |
14:26 | 1,008 @ 36.50p |
14:26 | 5,060 @ 36.50p |
14:26 | 1,062 @ 36.80p |
CEO | James Henry Barder |
Finance Director | Angela Hildreth |
You are here: research